Related Experiment Video
Updated: Jun 4, 2026

Static Adhesion Assay for the Study of Integrin Activation in T Lymphocytes
Published on: June 13, 2014
Function and histopathology of a cell adhesion molecule TSLC1 in cancer
Qi-Lian Liang1, Guo-Qiang Chen, Zhou-Yu Li
1Department of Oncology, Affiliated Hospital of Guangdong Medical College, Zhanjiang, China. qilianl@yahoo.com
Abstract:
Even less than a decade since the discovery of TSLC1, overwhelming evidence demonstrates that the loss of TSLC1 expression by methylation-mediated epigenetic silencing or LOH is crucially implicated in various processes during tumorigenesis. Here, we summarize TSLC1 function, highlighting the concept that TSLC1 mediates the formation of tumor suppressor network via its multidomain structure and bridges extracellular adhesive activity with intracellular signaling. Next, we focus on the histopathology of TSLC1 in various cancers and the association with clinicopathological characteristics. On the basis of these, we propose that TSLC1 represents a promising biomarker for cancer diagnosis and a potential target for cancer therapy.
Insights
Tumor suppressor TSLC1 loss, through epigenetic silencing or LOH, drives cancer. TSLC1 links cell adhesion to intracellular signals, offering potential as a cancer biomarker and therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- TSLC1 (Tumor Suppressor in Lung Cancer 1) is crucial in tumorigenesis.
- Loss of TSLC1 expression via epigenetic silencing or Loss of Heterozygosity (LOH) is common in various cancers.
Purpose of the Study:
- To summarize TSLC1 function in tumor suppression.
- To review TSLC1's role in cancer histopathology and clinicopathological characteristics.
- To propose TSLC1 as a biomarker and therapeutic target.
Main Methods:
- Literature review and synthesis of existing research on TSLC1.
- Analysis of TSLC1's functional domains and signaling pathways.
- Correlation analysis of TSLC1 expression with cancer pathology and clinical features.
Main Results:
- TSLC1 mediates tumor suppressor network formation through its multidomain structure.
- TSLC1 connects extracellular adhesion to intracellular signaling pathways.
- TSLC1 expression levels correlate with specific cancer histopathology and clinical characteristics.
Conclusions:
- TSLC1 plays a vital role in preventing tumor formation.
- TSLC1 is a promising biomarker for cancer diagnosis.
- Targeting TSLC1 may offer a new therapeutic strategy for cancer treatment.
Related Concept Videos
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved in a...
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved in a...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Selectins
Intracellular Signaling Affects Focal Adhesions
Some...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
